Sanjay Rajagopalan, MD

Showing   of 14 results

Manufacturing air pollution.

Beyond Traditional Risk Factors: Environmental Drivers of Cardiovascular Disease

Innovations in Research

Collage of images depicting artificial intelligence.

How AI and the Built Environment Are Redefining Obesity Risk

UH Research & Education Institute

Illustration of cyber heart.

How University Hospitals Harrington Heart & Vascular Institute is Harnessing Artificial Intelligence to Improve Cardiovascular Health

Innovations in Cardiovascular Medicine & Surgery | June 2026

Ian Neeland, MD UH Cardiovascular Medicine discussing in conference room

Leaders of Successful Cardiometabolic Program at University Hospitals Detail Essential Components

Innovations in Cardiovascular Medicine & Surgery | February 2025

Sanjay Rajagopalan, MD

UH Cardiovascular Medicine Chief Authors Roadmap to More Sustainable Cardiovascular Practice

Innovations in Cardiovascular Medicine & Surgery | December 2024

Sanjay Rajagopalan, MD

Sanjay Rajagopalan, MD, Leads Clinical Trial Showing Mechanism of Benefit of Mineralocorticoid Receptor Antagonist for Patients with Type 2 Diabetes and Chronic Kidney Disease

Innovations in Cardiovascular Medicine & Surgery | Fall 2024

Sanjay Rajagopalan, MD

UH Harrington Heart Vascular Institute’s Chief of Cardiovascular Medicine Co-Authors Three Major Publications on Environmental Impacts in Cardiovascular Health

Recent publications lay out a roadmap and call to action - Innovations of Cardiovascular Medicine & Surgery | Winter 2024

Groundbreaking Review of Air Pollution’s Effect on Cardiometabolic Risk Published in Lancet Diabetes Endocrinology

Innovations in Cardiovascular Medicine & Surgery | February 2024

Results are loading...